AI × Biotech Revolution: How Genomics, CRISPR & Machine Learning Are Accelerating Drug Discovery

Discover how AI and biotech are joining forces to transform drug development—from genomics and CRISPR target validation to machine learning–driven compound design and high-throughput screening. In this episode of TechDaily.AI (brought to you by StoneFly), we cover:

• Omics Insights: Mining genomics, transcriptomics, proteomics & metabolomics to pinpoint targets
• Gene Editing: Using CRISPR and CAR-T engineering for precision therapies
• AI in Drug Design: Leveraging ML/DL for toxicity prediction, ADME modeling & de novo molecule generation
• Automation & Scale: High-throughput assays, synthetic biology platforms (e.g., engineered yeast)
• Clinical Acceleration: AI-powered patient matching for faster trials
• Roadmap & Challenges: Data quality, explainable AI, vendor collaboration & regulatory readiness

Tune in to learn how this synergy is cutting R&D costs, speeding timelines, and paving the way for personalized medicine.